Merck Plans Phase III Prevymis CMV Trials In Renal Transplant Patients

 
• By Sten Stovall
  
CMV
Merck Hopes To Use First-Mover CMV Advantage In Kidney Transplant Patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas